Neuroscience News and Research

RSS

UC awarded $2.1 million technology award to develop next generation brain monitors

The U.S. Department of Defense has awarded researchers at the University of Cincinnati (UC) a $2.1 million Advanced Technology/Therapeutic Development Award to develop the next generation of brain monitors.

19 Oct 2010

Researchers discover how cocaine corrupts brains' reward center

Mount Sinai researchers have discovered how cocaine corrupts the brain and becomes addictive. These findings-the first to connect activation of specific neurons to alterations in cocaine reward-were published in Science on October 15. The results may help researchers in developing new ways of treating those addicted to the drug.

19 Oct 2010

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer's disease and other neurological disorders of the brain. A new Penn study, published this week in the Journal of Neuroscience, has found and tested in an animal model of Alzheimer's disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.

19 Oct 2010

Transcept announces Intermezzo tablet preliminary data for insomnia

Transcept Pharmaceuticals, Inc. today announced its preliminary analysis of data from the recently completed Intermezzo 3.5 mg (zolpidem tartrate sublingual tablet) highway driving study.

19 Oct 2010

Vitamin B12 may help protect against Alzheimer's disease

A new study shows that vitamin B12 may protect against Alzheimer's disease, adding more evidence to the scientific debate about whether the vitamin is effective in reducing the risk of memory loss. The research will be published in the October 19, 2010, issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Oct 2010

UCSF professor receives National Medal of Science

UCSF Nobel laureate Stanley B. Prusiner, MD, UCSF professor of neurology and director of the Institute for Neurodegenerative Diseases, today (Oct. 15, 2010) was named to receive the National Medal of Science, the nation's highest honor for science and technology.

18 Oct 2010

New tool could help researchers understand the neural basis of olfaction

Harvard University neurobiologists have created mice that can "smell" light, providing a potent new tool that could help researchers better understand the neural basis of olfaction.

18 Oct 2010

UT Dallas researcher receives NIH grant

For the second time this year, a postdoctoral fellow in UT Dallas' Center for Vital Longevity has earned a prestigious, highly competitive career-development grant from the National Institutes of Health (NIH).

18 Oct 2010

Biogen, Elan announce clinical utility data of two-step ELISA to detect anti-JCV antibodies

Biogen Idec and Elan Corporation, plc today announced data further supporting the potential clinical utility of an investigational assay that detects anti-JC virus (JCV) antibodies in human plasma or serum.

18 Oct 2010

Genetic link to depression: New avenues for therapy

Yale University scientists have found a gene that appears to play a key role in the onset of depression. This could mean new avenues of therapy for the disease. The gene in question is called MKP-1 and was identified after comparing the genetic codes of 21 deceased people who had been diagnosed with depression with those of 18 otherwise healthy individuals. The findings were published in the journal Nature Medicine on 17th of October.

18 Oct 2010

Teva Pharmaceutical announces new data from PreCISe study

Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.

18 Oct 2010

AstraZeneca launches new campaign on depression through Facebook and Twitter

AstraZeneca is launching a new campaign called "Take on Depression" through a "Take on Depression" Facebook page and a @FaceDepression Twitter feed to support, educate, and inspire those affected by bipolar depression and major depressive disorder (MDD), also known as depression.

15 Oct 2010

Knopp Neurosciences forms new parent entity

Knopp Neurosciences Inc. announced today that it has formed a new parent entity called Knopp Biosciences LLC to expand operations with the goal of becoming a more broadly integrated biopharmaceutical company.

15 Oct 2010

Fluctuations in internal body temperature regulate body's circadian rhythm: Research

Researchers at UT Southwestern Medical Center have found that fluctuations in internal body temperature regulate the body's circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions.

15 Oct 2010

Study finds TMS is an effective treatment solution for major depression

Transcranial magnetic stimulation (TMS), the treatment delivers a series of electrical pulses to the part of the brain associated with depression and other mood disorders. The pulses generate an electric current in the brain that stimulates neurons to increase the release of more mood-enhancing chemicals like serotonin, dopamine and norepinephrine.

15 Oct 2010

Think Pink event offers information on breast care to lead healthier life

In recognition of Breast Cancer Awareness Month in October, Washington Women's Center is hosting "Think Pink Event: Breast Health - Navigating Uncertain Waters," which will take place on Thursday, October 14, from 5 to 7:30 p.m. under the tent atrium at Washington West, located at 2500 Mowry Ave. in Fremont, in the parking lot adjacent to Civic Center Road.

14 Oct 2010

'Brain-computer interface' development receives Arizona Biomedical Research Commission grant

Efforts to advance technology to aid people who have lost communication and movement abilities are getting support from an Arizona Biomedical Research Commission grant for a project combining resources and expertise at Arizona State University and the Children's Neuroscience Institute at Phoenix Children's Hospital.

14 Oct 2010

Galenea awarded $4.5M NIMH grant to advance Multiwell, Automated NeuroTRansmission Assay platform

Galenea Corp. has been awarded a highly competitive grant from the National Institute of Mental Health in response to the solicitation "Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)," funded by the American Recovery and Reinvestment Act of 2009. Galenea has developed an innovative technology platform, termed MANTRA™ (Multiwell, Automated NeuroTRansmission Assay) that enables high-throughput screening for the identification of small molecule modulators of synaptic transmission.

14 Oct 2010

ApoE4 protein causes GABAergic interneuron loss, learning and memory deficits

Alzheimer's disease (AD) is an extremely complicated disease. Several proteins seem to be involved in its cause and progression. For example, the lipid-transport protein apolipoprotein E4 (apoE4) is the major genetic risk factor for AD, and apoE4 carriers account for 65% of all Alzheimer's cases, but exactly how apoE4 contributes to the disease is unclear.

14 Oct 2010

Stimulating brain's nicotine receptors may eliminate side effects of Alzheimer's drug: Research

A team of neuroscientists has discovered important new information in the search for an effective treatment for Alzheimer's disease, the debilitating neurological disorder that afflicts more than 5.3 million Americans and is the sixth-leading cause of death in the United States. Hey-Kyoung Lee, associate professor in the University of Maryland Department of Biology, and her research team have shown that they may be able to eliminate debilitating side effects caused by a promising Alzheimer's drug by stimulating the brain's nicotine receptors.

14 Oct 2010

Neuroscience News and Research

UC awarded $2.1 million technology award to develop next generation brain monitors

Researchers discover how cocaine corrupts brains' reward center

Study suggests epoD; microtubule-stabilizing drugs may treat neurodegenerative diseases

Transcept announces Intermezzo tablet preliminary data for insomnia

Vitamin B12 may help protect against Alzheimer's disease

UCSF professor receives National Medal of Science

New tool could help researchers understand the neural basis of olfaction

UT Dallas researcher receives NIH grant

Biogen, Elan announce clinical utility data of two-step ELISA to detect anti-JCV antibodies

Genetic link to depression: New avenues for therapy

Teva Pharmaceutical announces new data from PreCISe study

AstraZeneca launches new campaign on depression through Facebook and Twitter

Knopp Neurosciences forms new parent entity

Fluctuations in internal body temperature regulate body's circadian rhythm: Research

Study finds TMS is an effective treatment solution for major depression

Think Pink event offers information on breast care to lead healthier life

'Brain-computer interface' development receives Arizona Biomedical Research Commission grant

Galenea awarded $4.5M NIMH grant to advance Multiwell, Automated NeuroTRansmission Assay platform

ApoE4 protein causes GABAergic interneuron loss, learning and memory deficits

Stimulating brain's nicotine receptors may eliminate side effects of Alzheimer's drug: Research

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News